The longevity tech market map
Using CB Insights predictive signals, we mapped out the 84 startups shaping the future of longevity.
Article Metadata
Oct 22, 2025
Drug R&D
Book of Scouting Reports: AI in Clinical Development
We dive into the data on high-momentum AI companies in clinical development, including key financial metrics, opportunities, and threats.
Article Metadata
Oct 3, 2025
Book of Scouting Reports: AI in Preclinical Development
We dive into the data on high-momentum, private AI companies targeting the preclinical development stage of drug R&D.
Article Metadata
Sep 25, 2025
Book of Scouting Reports: AI Drug Discovery
We dive into the data on high-momentum, private generative AI companies in drug discovery, including key financial metrics, opportunities, and threats.
Article Metadata
Sep 19, 2025
Oncology tech in 4 charts: From downturn to record pace as AI innovation attracts renewed investment
We break down the oncology tech landscape across funding trends, M&A, exit probability, and more.
Article Metadata
Sep 8, 2025
AI Readiness Benchmark: The companies best positioned to lead the AI era
In this webinar, our industry experts reveal which companies are best positioned to lead the AI charge and how they stack up across critical readiness metrics.
Article Metadata
Jul 29, 2025
State of Digital Health Q2’25 Report
Digital health deal activity hit a 5-year low in Q2'25. Yet, billion-dollar IPOs returned, and AI captured a record funding share. We break down the quarter’s biggest deals and trends, using CB Insights data.
Article Metadata
Jul 24, 2025
Inside Novo Nordisk’s $33B manufacturing push to strengthen its obesity portfolio and build a biologics powerhouse
We mined Novo Nordisk’s acquisitions, investments, and partnerships to discern its strategic priorities and future plans.
Article Metadata
Apr 25, 2025
AI in Pharma: The New Playbook for Drug Research & Development
In this webinar, our expert breaks down AI’s impact across the entire R&D pipeline – from discovery to FDA approval.
Article Metadata
Apr 10, 2025
7 tech M&A predictions for 2025
AI will be the driving force behind tech M&A deals in 2025. From AI agent consolidation to big tech’s next battlefield, we highlight 7 areas where we expect to see deals this year.
Article Metadata
Mar 21, 2025
AI in clinical trials: How the tech is serving pharma’s riskiest bet
From deal activity to top investors, we analyze the shifting landscape for AI in clinical trials to determine how the tech is transforming drug development for the better.
Article Metadata
Mar 17, 2025
The generative AI in healthcare and life sciences market map
From clinical operations to drug development, we mapped 85+ startups bringing generative AI to the healthcare and life sciences industries.
Article Metadata
Mar 11, 2025
Analyzing Eli Lilly’s growth strategy: How the pharma giant is leveraging AI and pioneering a direct-to-patient approach
We analyzed Eli Lilly’s tech-focused acquisitions, investments, and partnerships to discern the company’s strategic priorities.
Article Metadata
Oct 7, 2024
Prioritizing clinical trials tech: How 16 tech-driven markets stack up across maturity and momentum
This report uses the CB Insights TECH Framework to rank clinical trials markets based on current commercial readiness and momentum.
Article Metadata
Sep 11, 2024
